Literature DB >> 9706060

Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier.

A Reichel1, D J Begley.   

Abstract

PURPOSE: The present study evaluates immobilized artificial membrane (IAM) chromatography for predicting drug permeability across the blood-brain barrier (BBB) and outlines the potential and limitations of IAMs as a predictive tool by comparison with conventional methods based on octanol/water partitioning and octadecylsilane (ODS)-HPLC.
METHODS: IAM-and ODS-HPLC capacity factors were determined in order to derive the hydrophobic indices log kIAM nad log kW for two sets of compounds ranging from very lipid soluble (steroids) to more hydrophilic agents (biogenic amines). The uptake of the compounds across the in vivo BBB expressed as brain uptake index (BUI) has been correlated with these HPLC capacity factors as well as octanol/ water partition (ClogP) and distribution coefficients (log D7.4).
RESULTS: For both test groups log kIAM correlates significantly with the respective log BUI of the drug (r2 = 0.729 and 0.747, p < 0.05), whereas with log kW, log D7.4 and ClogP there is only a correlation for the group of steroids (r2 = 0.789, 0.659 and 0.809, p < 0.05) but not for the group of biogenic amines. There is a good correlation between log kIAM and log kW. ClogP or log D7.4 for the group of steroids (r2 = 0.945.0867 and 0.974, p < 0.01) but not for the biogenic amines.
CONCLUSIONS: All physico-chemical descriptors examined in this study equally well describe brain uptake of lipophilic compounds, while log kIAM is superior over log D7.4, ClogP and log kW when polar and ionizable compounds are included. The predictive value of IAMs, combined with the power of HPLC holds thus great promise for the selection process of drug candidates with high brain penetration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706060     DOI: 10.1023/a:1011904311149

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Fatty acid composition of brain capillary endothelial cells: effect of the coculture with astrocytes.

Authors:  C Bénistant; M P Dehouck; J C Fruchart; R Cecchelli; M Lagarde
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

Review 2.  Transporting therapeutics across the blood-brain barrier.

Authors:  N J Abbott; I A Romero
Journal:  Mol Med Today       Date:  1996-03

3.  Predicting blood-brain transport of drugs: a computational approach.

Authors:  S C Basak; B D Gute; L R Drewes
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

4.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists.

Authors:  R C Young; R C Mitchell; T H Brown; C R Ganellin; R Griffiths; M Jones; K K Rana; D Saunders; I R Smith; N E Sore
Journal:  J Med Chem       Date:  1988-03       Impact factor: 7.446

Review 5.  The blood-brain barrier.

Authors:  M W Bradbury
Journal:  Exp Physiol       Date:  1993-07       Impact factor: 2.969

6.  Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces.

Authors:  S Ong; H Liu; X Qiu; G Bhat; C Pidgeon
Journal:  Anal Chem       Date:  1995-02-15       Impact factor: 6.986

Review 7.  Hydrophobicity estimations by reversed-phase liquid chromatography. Implications for biological partitioning processes.

Authors:  J G Dorsey; M G Khaledi
Journal:  J Chromatogr       Date:  1993-12-17

8.  The pH-dependence in the partitioning behaviour of (RS)-[3H]propranolol between MDCK cell lipid vesicles and buffer.

Authors:  S D Krämer; H Wunderli-Allenspach
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

9.  Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults.

Authors:  E M Cornford; L D Braun; W H Oldendorf; M A Hill
Journal:  Am J Physiol       Date:  1982-09

10.  Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.

Authors:  W M Pardridge; L J Mietus
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

View more
  13 in total

1.  Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity.

Authors:  Dharmendra Kumar Yadav; Feroz Khan; Arvind Singh Negi
Journal:  J Mol Model       Date:  2011-10-27       Impact factor: 1.810

2.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

Review 3.  Review Article: Capturing the physiological complexity of the brain's neuro-vascular unit in vitro.

Authors:  Hossein Heidari; Hayden Taylor
Journal:  Biomicrofluidics       Date:  2018-10-16       Impact factor: 2.800

4.  Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water.

Authors:  Y N Kaznessis; M E Snow; C J Blankley
Journal:  J Comput Aided Mol Des       Date:  2001-08       Impact factor: 3.686

Review 5.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

6.  Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.

Authors:  Markus Muehlbacher; Gudrun M Spitzer; Klaus R Liedl; Johannes Kornhuber
Journal:  J Comput Aided Mol Des       Date:  2011-11-23       Impact factor: 3.686

7.  Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis.

Authors:  Manisha Iyer; Rama Mishra; Yi Han; A J Hopfinger
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

8.  Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties.

Authors:  Keigo Hirai; Hiroko Yamashita; Shusuke Tomoshige; Yugo Mishima; Tatsuya Niwa; Kenji Ohgane; Mayumi Ishii; Kayoko Kanamitsu; Yui Ikemi; Shinsaku Nakagawa; Hideki Taguchi; Shinichi Sato; Yuichi Hashimoto; Minoru Ishikawa
Journal:  ACS Med Chem Lett       Date:  2022-02-16       Impact factor: 4.345

9.  Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

Authors:  Scott D Campbell; Karen J Regina; Evan D Kharasch
Journal:  J Biomol Screen       Date:  2013-08-14

10.  Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development.

Authors:  R Pignatello; T Musumeci; L Basile; C Carbone; G Puglisi
Journal:  J Pharm Bioallied Sci       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.